ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 08, 2021
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 2331 - 2340 လၢ 4030 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP98-21 Commercial Pharmacy Benefit Exclusion for Nulojix® and Susvimo™
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 08, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP99-21 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 08, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP100-21 Checks to be Sent for Unpaid Prompt Pay Penalties
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 08, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 08, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
2021 December Provider Press
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 03, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
BCBSMN-Upcoming-policies-effective-013122.pdf
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P61R1-21 Update: Evaluation and Management Reimbursement Changes
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 01, 2021
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P68R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါဒံၣ်စဲဘၢၣ် 01, 2021